Fred Charatan. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Cyclooxygenase 2 Inhibitors/adverse effectsCyclooxygenase 2 Inhibitors/economicsDrug Industry/economicsDrug Industry/legislation & jurisprudenceJurisprudenceLactones/adverse effectsLactones/economicsSulfones/adverse effectsSulfones/economicsUnited States
Substances: See more » Cyclooxygenase 2 InhibitorsLactonesSulfonesrofecoxib
Year: 2007 PMID: 18006982 PMCID: PMC2078665 DOI: 10.1136/bmj.39398.517176.DB
Source DB: PubMed Journal: BMJ ISSN: 0959-8138